Summary
Healthy humans undergoing hemipancreatectomy for the purpose of donation to a family member with IDDM have previously been demonstrated to maintain serum glucose values equal to matched control subjects during short-term glucose infusion despite significant decrements in glucose- and arginine-induced insulin secretion. In order to determine whether humans compensate for hemipancreatectomy by increasing insulin- or glucose-mediated glucose uptake, we measured glucose turnover and insulin sensitivity by three protocols. Insulin-mediated glucose uptake was measured during sequential infusions of insulin at rates of 0.25, 1.0, and 10.0 mU·kg−1·min−1 in 12 donor subjects and 12 matched control subjects maintained at euglycaemia. Both groups displayed similar increases in rates of glucose disappearance and similar decreases in rates of hepatic glucose production. Glucose-mediated uptake was calculated as the difference between the rates of glucose disappearance measured during a hyperglycaemic clamp and a euglycaemic clamp performed at identical rates of insulin infusion and was also found to be similar in both donor subjects and control subjects. Both groups also had indistinguishable measures of insulin sensitivity and glucose effectiveness as determined by the minimal model technique. Therefore, donor subjects appear to compensate for diminished insulin secretion following hemipancreatectomy by an unidentified mechanism since neither insulin- nor glucose-mediated glucose uptake are increased.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- Rd :
-
Rate of glucose disappearance
- HGP:
-
hepatic glucose production rate
- IDDM:
-
insulin-dependent diabetes mellitus
- SI :
-
insulin sensitivity index
- SG :
-
glucose effectiveness
References
Sun AM, Coddling JA, Haist RE (1974) A study of glucose tolerance and insulin response in partially depancreatized dogs. Diabetes 23: 424–432
Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induces insulin release. J Clin Invest 71: 1544–1553
Leahy JL, Bonner-Weir S, Weir GC (1984) Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33: 667–673
Rossetti L, Shulman GI, Zawalich W, DeFronzo RA (1987) Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80: 1037–1044
Leahy JL, Bonner-Weir S, Weir GC (1988) Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81: 1407–1414
Ward WK, Wallum BJ, Beard JC, Taborsky GJ, Porte D (1988) Reduction of glycemic potentiation. Sensitive indicator of Β-cell loss in partially pancreatectomized dogs. Diabetes 37: 723–729
Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP (1990) Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322: 898–903
Seaquist ER, Robertson RP (1992) Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 89: 1761–1766
Gottesman I, Mandarino L, Gerich J (1983) Estimation and kinetic analysis of insulin-independent glucose uptake in human subjects. Am J Physiol 244: E632-E635
Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79: 790–800
Morgan CR, Lazarow A (1963) Immunoassay of insulin: two antibody system. Diabetes 12: 115–126
Harris V, Faloona GR, Unger RH (1979) Glucagon. In: BM Jaffe, HR Behrman (eds) Methods of hormone radioimmunoassay. Academic Press, New York, p. 643
Somogyi M (1945) Determination of blood sugar. J Biol Chem 160: 69–73
Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabelled and labelled exogenous glucose infusates. Diabetes 36: 914–924
Steele R, Wall JS, DeBodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15–24
DeBodo RC, Steele R, Altszuler N, Dunn A, Bishop JS (1963) On the hormonal regulation of carbohydrate metabolism; studies with C14 glucose. Rec Prog Horm Res 19: 445–488
Gotoh M, Monden M, Okamura J, Mori T, Shima K (1989) Insulin and glucagon secretion after pancreatectomies. Correlation of secretion and hormonal contents of remaining pancreas. Diabetes 38: 861–867
Gersell DJ, Gingerich RL, Greider MH (1979) Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes 28: 11–15
Magnusson J, Bengmark S, Tranberg K-G (1990) Reduced insulin secretion by subtotal pancreatectomy: preservation of insulin sensitivity and glucose tolerance in postoperative patients. Scand J Gastroenterol 25: 669–675
Steiner KE, Williams PE, Lacy WW, Cherrington AD (1990) Effects of insulin on glucagon-stimulated glucose production in the conscious dog. Metabolism 39: 1325–1333
Bajorunas DR, Dresler CM, Horowitz GD et al. (1986) Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance. Diabetes 35: 556–562
Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and Β-cell function in human subjects. Diabetes 42: 1663–1672
Katz H, Homan M, Velosa J, Robertson P, Rizza R (1991) Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 325: 1278–1283
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seaquist, E.R., Pyzdrowski, K., Moran, A. et al. Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia 37, 1036–1043 (1994). https://doi.org/10.1007/BF00400467
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400467